MedTrace Logo

Cytological Examination of Malignant Pleural Effusion in Breast Cancer

NCT06657638 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-05-29

No results posted yet for this study

Summary

Malignant pleural effusion (MPE) is characterized by the presence of malignant cells. It can occur in 15% of patients with cancer and is a common manifestation in patients with metastatic disease.

Breast cancer (BC) is the second most common cause of MPE and MPE occurring in 2- 11% of patients with BC. Breast cancer is a heterogeneous disease of malignant tumors with diversified morphology, clinical course, biologic behavior and prognosis, and accurate tumor classification is critical for a patient's care.

Conditions

  • Malignant Pleural Effusion

Interventions

DIAGNOSTIC_TEST

Thoracentesis

Aspiration of pleural effusion

Sponsors & Collaborators

  • Mansoura University Hospital

    lead OTHER

Principal Investigators

  • Mohamed AbdElmoniem · Mansoura University

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-19
Primary Completion
2025-01-19
Completion
2025-04-19

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06657638 on ClinicalTrials.gov